[[abstract]]We discuss logrank test-based methods for early efficacy or futility evaluation in group-sequential clinical trials designed to compare two interventions using two time-to-event outcomes. We consider three typical situations (1) both events are non-composite and nonfatal, (2) both events are non-composite but one event is fatal, and (3) one event is composite but other is fatal and non-composite. We outline strategies for rejecting the null hypothesis associated with two inferential goals, evaluating if a test intervention is superior to a control intervention on: (1) both outcomes (multiple co-primary endpoints: MCPE), and (2) at least one outcome (multiple primary endpoints: MPE). We provide an example to illustrate the method...
The last 10 years have seen considerable interest in clinical trial designs that allow the seamless ...
[[abstract]]We investigate selection of critical boundary functions for testing the hypotheses of tw...
Group sequential methods find a particular field of application in clinical trials because patient r...
[[abstract]]We discuss logrank test-based methods for early efficacy or futility evaluation in group...
This book focuses on group sequential methods for clinical trials with co-primary endpoints based on...
Background: A common feature of many recent trials evaluating the effects of immunotherapy on surviv...
There is increasing interest in combining Phases II and III of clinical development into a single tr...
This article develops methods of statistical monitoring of clinical trials with multiple co-primary ...
OBJECTIVE: Usually, sequential designs for clinical trials are applied on the primary (=efficacy) ou...
A group-sequential (design for clinical trials that involve treatment selection was proposed by Stal...
Biomarker-guided clinical trial designs, which focus on testing the effectiveness of a biomarker-gui...
In clinical trials, situations often arise where more than one response from each patient is of inte...
In the analysis of composite endpoints in a clinical trial, time to first event analysis techniques ...
Background Data from clinical trials where the endpoint is a single survival time are readily analys...
Sequential methods provide a formal framework by which clinical trial data can be monitored as they ...
The last 10 years have seen considerable interest in clinical trial designs that allow the seamless ...
[[abstract]]We investigate selection of critical boundary functions for testing the hypotheses of tw...
Group sequential methods find a particular field of application in clinical trials because patient r...
[[abstract]]We discuss logrank test-based methods for early efficacy or futility evaluation in group...
This book focuses on group sequential methods for clinical trials with co-primary endpoints based on...
Background: A common feature of many recent trials evaluating the effects of immunotherapy on surviv...
There is increasing interest in combining Phases II and III of clinical development into a single tr...
This article develops methods of statistical monitoring of clinical trials with multiple co-primary ...
OBJECTIVE: Usually, sequential designs for clinical trials are applied on the primary (=efficacy) ou...
A group-sequential (design for clinical trials that involve treatment selection was proposed by Stal...
Biomarker-guided clinical trial designs, which focus on testing the effectiveness of a biomarker-gui...
In clinical trials, situations often arise where more than one response from each patient is of inte...
In the analysis of composite endpoints in a clinical trial, time to first event analysis techniques ...
Background Data from clinical trials where the endpoint is a single survival time are readily analys...
Sequential methods provide a formal framework by which clinical trial data can be monitored as they ...
The last 10 years have seen considerable interest in clinical trial designs that allow the seamless ...
[[abstract]]We investigate selection of critical boundary functions for testing the hypotheses of tw...
Group sequential methods find a particular field of application in clinical trials because patient r...